NO20065609L - Piperazinderivater av alkyloksindoler. - Google Patents

Piperazinderivater av alkyloksindoler.

Info

Publication number: NO20065609L
Authority: NO; Norway
Prior art keywords: alkyloxindoles; piperazine derivatives; derivatives; prophylaxis; therapy
Prior art date: 2004-05-11

Application number

NO20065609A

Other languages

English (en)

Norwegian (no)

Inventor

Jozsef Barkoczy

Tibor Mezei

Gyula Simig

Balazs Volk

Dezsofi Rita Kapillerne

Original Assignee

Egyt Gyogyszervegyeszeti Gyar

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-05-11

Filing date

2006-12-05

Publication date

2007-02-05

2006-12-05 Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar

2007-02-05 Publication of NO20065609L publication Critical patent/NO20065609L/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Heart & Thoracic Surgery (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Reproductive Health (AREA)
Endocrinology (AREA)
Vascular Medicine (AREA)
Gynecology & Obstetrics (AREA)
Hospice & Palliative Care (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)

NO20065609A 2004-05-11 2006-12-05 Piperazinderivater av alkyloksindoler. NO20065609L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU0400953A HUP0400953A3 (en)	2004-05-11	2004-05-11	Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
PCT/HU2005/000050 WO2005108364A1 (fr)	2004-05-11	2005-05-11	Derives de piperazine d'alkyl oxindoles

Publications (1)

Publication Number	Publication Date
NO20065609L true NO20065609L (no)	2007-02-05

Family

ID=89982207

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20065609A NO20065609L (no)	2004-05-11	2006-12-05	Piperazinderivater av alkyloksindoler.

Country Status (27)

Country	Link
US (1)	US7910591B2 (fr)
EP (1)	EP1751105B1 (fr)
JP (1)	JP2007537227A (fr)
CN (1)	CN101010296B (fr)
AT (1)	ATE412633T1 (fr)
AU (1)	AU2005240843B2 (fr)
BG (1)	BG109769A (fr)
CA (1)	CA2566096A1 (fr)
CZ (1)	CZ2006779A3 (fr)
DE (1)	DE602005010693D1 (fr)
DK (1)	DK1751105T3 (fr)
EA (1)	EA010789B1 (fr)
ES (1)	ES2319795T3 (fr)
HR (1)	HRP20060420A2 (fr)
HU (1)	HUP0400953A3 (fr)
IL (1)	IL179028A (fr)
MX (1)	MXPA06013068A (fr)
NO (1)	NO20065609L (fr)
NZ (1)	NZ551545A (fr)
PL (2)	PL1751105T3 (fr)
PT (1)	PT1751105E (fr)
RS (1)	RS20060621A (fr)
SI (1)	SI1751105T1 (fr)
SK (1)	SK51102006A3 (fr)
UA (1)	UA84927C2 (fr)
WO (1)	WO2005108364A1 (fr)
ZA (1)	ZA200610345B (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUP0400953A3 (en) *	2004-05-11	2008-02-28	Egis Gyogyszergyar Nyilvanosan	Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use
CN104163813B (zh) *	2013-05-16	2017-02-01	广东东阳光药业有限公司	取代的吲哚化合物及其使用方法和用途
WO2016192657A1 (fr)	2015-06-03	2016-12-08	Sunshine Lake Pharma Co., Ltd.	Composés de pipérazine substitués, leurs procédés d'utilisation et leurs utilisations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4452808A (en) *	1982-12-07	1984-06-05	Smithkline Beckman Corporation	4-Aminoalkyl-2(3H)-indolones
MX173362B (es)	1987-03-02	1994-02-23	Pfizer	Compuestos de piperazinil heterociclicos y procedimiento para su preparacion
FR2635104B1 (fr) *	1988-08-03	1992-04-30	Synthelabo	Derives d'indolone, leur preparation et leur application en therapeutique
GB8830312D0 (en)	1988-12-28	1989-02-22	Lundbeck & Co As H	Heterocyclic compounds
WO1998008816A1 (fr) *	1996-08-26	1998-03-05	Meiji Seika Kaisha, Ltd.	Derives d'indoxyle et psychotropes
HUP0400953A3 (en) *	2004-05-11	2008-02-28	Egis Gyogyszergyar Nyilvanosan	Piperazine derivatives of alkyl-oxindoles, pharmaceutical compositions containing them, process for producing them and their use

2004
- 2004-05-11 HU HU0400953A patent/HUP0400953A3/hu unknown
2005
- 2005-05-11 ZA ZA200610345A patent/ZA200610345B/en unknown
- 2005-05-11 AT AT05745440T patent/ATE412633T1/de active
- 2005-05-11 SK SK5110-2006A patent/SK51102006A3/sk not_active Application Discontinuation
- 2005-05-11 SI SI200530564T patent/SI1751105T1/sl unknown
- 2005-05-11 WO PCT/HU2005/000050 patent/WO2005108364A1/fr not_active Ceased
- 2005-05-11 UA UAA200613076A patent/UA84927C2/ru unknown
- 2005-05-11 PL PL05745440T patent/PL1751105T3/pl unknown
- 2005-05-11 DK DK05745440T patent/DK1751105T3/da active
- 2005-05-11 CA CA002566096A patent/CA2566096A1/fr not_active Abandoned
- 2005-05-11 JP JP2007512357A patent/JP2007537227A/ja not_active Ceased
- 2005-05-11 DE DE602005010693T patent/DE602005010693D1/de not_active Expired - Lifetime
- 2005-05-11 HR HR20060420A patent/HRP20060420A2/xx not_active Application Discontinuation
- 2005-05-11 US US11/596,465 patent/US7910591B2/en not_active Expired - Fee Related
- 2005-05-11 AU AU2005240843A patent/AU2005240843B2/en not_active Expired - Fee Related
- 2005-05-11 ES ES05745440T patent/ES2319795T3/es not_active Expired - Lifetime
- 2005-05-11 EP EP05745440A patent/EP1751105B1/fr not_active Expired - Lifetime
- 2005-05-11 PL PL381615A patent/PL381615A1/pl unknown
- 2005-05-11 NZ NZ551545A patent/NZ551545A/en unknown
- 2005-05-11 EA EA200602084A patent/EA010789B1/ru not_active IP Right Cessation
- 2005-05-11 RS RSP-2006/0621A patent/RS20060621A/sr unknown
- 2005-05-11 MX MXPA06013068A patent/MXPA06013068A/es active IP Right Grant
- 2005-05-11 CZ CZ20060779A patent/CZ2006779A3/cs unknown
- 2005-05-11 CN CN2005800148934A patent/CN101010296B/zh not_active Expired - Fee Related
- 2005-05-11 PT PT05745440T patent/PT1751105E/pt unknown
2006
- 2006-11-02 IL IL179028A patent/IL179028A/en not_active IP Right Cessation
- 2006-12-05 NO NO20065609A patent/NO20065609L/no not_active Application Discontinuation
- 2006-12-11 BG BG109769A patent/BG109769A/bg unknown

Also Published As

Publication number	Publication date
AU2005240843B2 (en)	2012-02-02
EA200602084A1 (ru)	2007-04-27
ZA200610345B (en)	2008-05-28
CZ2006779A3 (cs)	2007-03-07
BG109769A (bg)	2008-03-31
US7910591B2 (en)	2011-03-22
AU2005240843A1 (en)	2005-11-17
US20080161323A1 (en)	2008-07-03
RS20060621A (sr)	2008-09-29
UA84927C2 (en)	2008-12-10
HUP0400953A2 (en)	2007-09-28
JP2007537227A (ja)	2007-12-20
DE602005010693D1 (de)	2008-12-11
HUP0400953A3 (en)	2008-02-28
WO2005108364A1 (fr)	2005-11-17
IL179028A (en)	2011-08-31
EA010789B1 (ru)	2008-10-30
ES2319795T3 (es)	2009-05-12
CA2566096A1 (fr)	2005-11-17
CN101010296A (zh)	2007-08-01
EP1751105A1 (fr)	2007-02-14
PT1751105E (pt)	2009-02-10
NZ551545A (en)	2010-07-30
HU0400953D0 (en)	2004-07-28
PL381615A1 (pl)	2007-06-11
ATE412633T1 (de)	2008-11-15
EP1751105B1 (fr)	2008-10-29
DK1751105T3 (da)	2009-03-09
MXPA06013068A (es)	2007-05-04
PL1751105T3 (pl)	2009-07-31
IL179028A0 (en)	2007-03-08
HRP20060420A2 (en)	2007-04-30
SK51102006A3 (sk)	2007-05-03
SI1751105T1 (sl)	2009-06-30
CN101010296B (zh)	2011-08-17

Publication	Publication Date	Title
NO20080981L (no)	2008-04-17	Nitrocatechol-derivater som COMT-inhibitorer
NO20082266L (no)	2008-05-16	Nye 1-azabicykloalkylderivater for behandling av psykotiske og neurodegenerative forstyrrelser
NO20061454L (no)	2006-07-06	Compounds having CRTH2 antagonist activity
NO20056130L (no)	2006-02-27	Nye substituerte 3-svovelindoler
NO20090166L (no)	2009-03-12	Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20083214L (no)	2008-09-01	Pyrimidinylarylurea-derivater som omdannes til FGF-inhibitorer
NO20073366L (no)	2007-09-21	1,6-substituert (3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-2,5-piperazindionderivater som oksytocinreceptorantagonister for behandling av for tidlige veer, dysmenorri og endometriose
NO20090755L (no)	2009-03-09	Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20080061L (no)	2008-04-07	Imidazolyl-pyrimidinforbindelser for anvendelse til behandling av proliferative lidelser
NO20080445L (no)	2008-01-23	Nye azetidinderivater som neurokininreseptorantagonister for behandling av gastrointestinale sykdommer
NO20090445L (no)	2009-02-26	Cykliske 11-beta hydroksysteroid-dehydrogenase type 1 inhibitorer
NO20071137L (no)	2007-04-19	Nye piperidinderivater for behandling av depresjon
DK2105164T3 (da)	2011-03-21	Nye P2X7R-antagonister og deres anvendelse
NO20075624L (no)	2007-11-28	Nye histamin H3-reseptorligander og deres terapeutiske anvendelser
NO20071504L (no)	2007-05-25	Pyrimidinderivanter.
NO20073113L (no)	2007-07-16	Indenylderivater og anvendelse derav for behandling av neurologiske lidelser
NI200700032A (es)	2007-08-03	Derivados arilsulfonilestilbeno para tratamiento de insomnio y afecciones relacionadas
NO20071254L (no)	2007-03-22	Fremgangsmate for fremstilling av irbesartan og mellomprodukter derav.
NO20052487L (no)	2005-05-24	1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
DE602007006643D1 (de)	2010-07-01	Bis-1,2,3,4-tetrahydroisochinolinderivate und ihre verwendung als pharmazeutika
NO20080553L (no)	2008-04-23	Azinyl-3-sulfonylindazolderivater som 5-hydroksytrypyamin-6 ligander
NO20071466L (no)	2007-04-19	3-substituerte-5- og 6-aminoalkyl indol-2-karboksylsyreamider og relaterte analoger som inhibitorer av kaseinkinase IE
NO20065609L (no)	2007-02-05	Piperazinderivater av alkyloksindoler.
NO20082459L (no)	2008-07-22	Nye prosesser for fremstilling av piperazinyl og diazapanylbenzamidderivater
NO20064491L (no)	2006-10-03	Nye difluomtoksysubstituee hydroksy-6-fenylfenantridiner og deres anvendelse som PDE4-inhibitorer

Legal Events

Date	Code	Title	Description
2012-12-27	FC2A	Withdrawal, rejection or dismissal of laid open patent application